XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric Cancer
NCT01412294
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Interventions
DRUG:
Capecitabine, Cisplatin
Sponsor
Epidemiological and Clinical Research Information Network